title: Toxicity and costs of toxicity associated with new cancer drugs: international implications.
authors.affiliation: Helsinki University Central Hospital, Helsinki, Finland.
authors.forename: Terhi
authors.initials: T
authors.lastname: Hermanson
authors.affiliation: William Jennings Bryan Dorn Veterans Administration Medical Center and the South Carolina College of Pharmacy, the University of South Carolina, Columbia, SC.
authors.forename: LeAnn B
authors.initials: LB
authors.lastname: Norris
authors.affiliation: South Carolina College of Pharmacy, the University of South Carolina, Columbia, SC.
authors.forename: John
authors.initials: J
authors.lastname: Bian
authors.affiliation: Tulane Cancer Center, Tulane University, New Orleans, LA.
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
authors.affiliation: Center for Medication Safety and Efficacy; the Arnold School of Public Health of the University of South Carolina; William Jennings Bryan Dorn Veterans Administration Medical Center; and Hollings Cancer Center of the Medical University of South Carolina, Columbia, SC bennettc@sccp.sc.edu.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Bennett
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology*; D015507:Drugs, Investigational / Q000009:adverse effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational